posted on 2007-11-29, 00:00authored byYonghui Zhang, Michael P. Hudock, Kilannin Krysiak, Rong Cao, Kyle Bergan, Fenglin Yin, Annette Leon, Eric Oldfield
We investigated three series of sulfonium bisphosphonates for their activity in inhibiting the growth of
three human tumor cell lines. The first series consisted of 6 cyclic sulfonium bisphosphonates, the most
active species having an (average) IC50 of 89 μM. The second consisted of 10 phenylalkyl and phenylalkoxy
bisphosphonates, the most active species having an IC50 of 18 μM. The third series consisted of 17 n-alkyl
sulfonium bisphosphonates, the most active species having an IC50 of ∼240 nM. Three QSAR models showed
that the experimental cell growth inhibition results could be well predicted. We also determined the structures
of one sulfonium bisphosphonate bound to farnesyl diphosphate synthase, finding that it binds exclusively
to the dimethylallyl diphosphate binding site. These results are of interest since they show that sulfonium
bisphosphonates can have potent activity against a variety of tumor cell lines, the most active species having
IC50 values much lower than conventional nitrogen-containing bisphosphonates.